C-KIT expression in ductal carcinoma in situ of the breast: Co-expression with HER-2/neu

Human Pathology

Volumn 37, Issue 2, 2006, Pages 205-211

  Diallo, Raihanatou ^a   Rody, Achim ^b   Jackisch, Christian ^c   Ting, Evelyn ^a   Schaefer, Karl Ludwig ^a   Kissler, Stefan ^b   Karn, Thomas ^b   Geddert, Helene ^a   Engels, Knut ^b   Kaufmann, Manfred ^b   Gabbert, Helmut E ^a   Shroyer, Kenneth R ^d   Poremba, Christopher ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

c KIT (CD117); Ductal carcinoma in situ; Estrogen receptor; HER 2 neu; Immunohistochemistry; Progesterone receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER GROWTH; CARCINOMA IN SITU; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NECROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 30744466882     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.10.015     Document Type: Article

References (37)

1. Y. Yarden, W.J. Kuang, and T. Yang-Feng Human proto-oncogene c-KIT: a new cell surface receptor tyrosine kinase for an unidentified ligand EMBO J 6 1987 3341 3351
2. K.M. Zsebo, D. Williams, and E. Geissler Stem cell factor is encoded at the S/locus of the mouse and is the ligand for the c-KIT tyrosine kinase receptor Cell 63 1990 213 224
3. K. Nocka, S. Majumder, and B. Chabot Expression of c-KIT gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-KIT kinase in mutant mice Genes Dev 3 1989 816 826
4. M.C. Heinrich, B.P. Rubin, B.J. Longley, and J.A. Fletcher Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations Hum Pathol 33 2002 484 495
5. C. Wang, J. Curtis, E. Geissler, E. McCulloch, and M. Minden The expression of the proto-oncogene c-KIT in the blast cells of acute myeloblastic leukemia Leukemia 3 1989 699 702
6. H. Plummer III, J. Catlett, and J. Leftwich c-myc expression correlates with suppression of c-KIT proto-oncogene expression in small cell lung cancer cell lines Cancer Res 53 1993 4337 4342
7. Q. Tian, H.F. Frierson, G.W. Krystal, and C.A. Moskaluk Activating c-KIT gene mutations in human germ cell tumors Am J Pathol 154 1999 1643 1647
8. S. Hirota, K. Isozaki, and Y. Moriyama Gain-of-function mutations of c-KIT in human gastrointestinal stromal tumors Science 279 1998 577 580
9. N. Lassam, and S. Bickford Loss of c-KIT expression in cultured melanoma cells Oncogene 7 1992 51 56
10. M. Miettinen, and J. Lasota Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis Virchows Arch 438 2001 1 12
11. M.L. Lux, B.P. Rubin, and T.L. Biase KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors Am J Pathol 156 2000 791 795
12. P.G. Natali, M.R. Nicotra, I. Sures, M. Mottolese, C. Botti, and A. Ullrich Breast cancer is associated with loss of the c-kit oncogene product Int J Cancer 52 1992 713 717
13. C.D. Ko, J.S. Kim, and B.G. Ko The meaning of the c-KIT proto-oncogene product in malignant transformation in human mammary epithelium Clin Exp Metastasis 20 2003 593 597
14. Y. Tsuura, T. Suzuki, K. Honma, and M. Sano Expression of c-KIT protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status J Cancer Res Clin Oncol 128 2002 239 246
15. X. Chui, H. Egami, and J. Yamashita Immunohistochemical expression of the c-KIT proto-oncogene product in human malignant and non-malignant breast tissues Br J Cancer 73 1996 1233 1236
16. P. Ulivi, W. Zoli, and L. Medri c-KIT and SCF expression in normal and tumor breast tissue Breast Cancer Res Treat 83 2004 33 42
17. Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee Cancer 80 1997 1798 1802
18. W. Remmele, and H.E. Stegner Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathology 8 1987 138 140
19. H. Tsuda, D. Morita, and M. Kimura Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation Cancer Sci 96 2005 48 53
20. A. Bankfalvi, G. Giuffre, and D. Ofner Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis Int J Oncol 23 2003 1285 1292
21. H. Yamamoto, Y. Oda, and K. Kawaguchi c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue) Am J Surg Pathol 28 2004 479 488
22. G.L. Ottesen Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study APMIS Suppl 2003 1 67
23. M.C. Heinrich, C.D. Blanke, B.J. Druker, and C.L. Corless Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies J Clin Oncol 20 2002 1692 1703
24. R. Simon, S. Panussis, and R. Maurer KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations Clin Cancer Res 10 2004 178 183
25. S. Carvalho, A.O. e Silva, and F. Milanezi c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations? J Clin Pathol 57 2004 1075 1079
26. E.J. Sawyer, R. Poulsom, and F.T. Hunt Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit J Pathol 200 2003 59 64
27. S.P. Wilczynski, Y.Y. Chen, W. Chen, S.B. Howell, J.E. Shively, and D.S. Alberts Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers Hum Pathol 36 2005 242 249
28. T. Baqai, and S. Shousha Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast Histopathology 42 2003 440 447
29. T.O. Nielsen, F.D. Hsu, and K. Jensen Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374
30. S. Palmu, K.O. Soderstrom, K. Quazi, J. Isola, and E. Salminen Expression of C-KIT and HER-2 tyrosine kinase receptors in poor-prognosis breast cancer Anticancer Res 22 2002 411 414
31. T. Sorlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
32. K. Araki, G. Ishii, and T. Yokose Frequent overexpression of the c-KIT protein in large cell neuroendocrine carcinoma of the lung Lung Cancer 40 2003 173 180
33. G. Bar-Sela, A. Kuten, S. Ben-Eliezer, E. Gov-Ari, and O. Ben-Izhak Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach Mod Pathol 16 2003 1035 1040
34. G. Pelosi, M. Barisella, and F. Pasini CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients Mod Pathol 17 2004 711 721
35. P. Kauraniemi, S. Hautaniemi, and R. Autio Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines Oncogene 23 2004 1010 1013
36. S.J. Hines, J.S. Litz, and G.W. Krystal Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors Breast Cancer Res Treat 58 1999 1 10
37. T. von Ruden, L. Stingl, A. Ullrich, and E.F. Wagner Rescue of W-associated mast cell defects in W/Wv bone marrow cells by ectopic expression of normal and mutant epidermal growth factor receptors Blood 82 1993 1463 1470